MEG3 and breast carcinoma: In breast cancer, reduced expression of MEG3 was correlated with disease‐specific survival of breast cancer.43 Our results indicated that expression of MEG3 was low in breast cancer when compared with normal tissues, and low MEG3 expression represented a better overall survival.